3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
34
Rectal Neoplasms
22
Triple Negative Breast Neoplasms
16
Stomach Neoplasms
16
Colorectal Neoplasms
13
Neoplasm Metastasis
9
Adenocarcinoma
9
Pancreatic Neoplasms
8
Esophageal Neoplasms
8
Adenocarcinoma Of Esophagus
7
Neoplasms
5
Nasopharyngeal Carcinoma
5
Biliary Tract Neoplasms
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Carcinoma, Non-Small-Cell Lung
4
Esophageal Squamous Cell Carcinoma
3
Colonic Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Spinocerebellar Degenerations
2
Ovarian Neoplasms
2
Neoplasm, Residual
2
Carcinoma
2
Anus Neoplasms
2
Advanced Solid Tumour
2
Somatostatinoma
1
Solid Tumors
1
Resectable Colon Cancer
1
Rectal Cancer Patients
1
Peritoneal Neoplasms
1
Pathologic Complete Response
1
Interventions
Magnetic Resonance Spectroscopy
6
Biopsy
6
X-Rays
5
Specimen Handling
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
4
Cisplatin
3
Carboplatin
3
tazemetostat
2
selpercatinib
2
larotrectinib
2
erdafitinib
2
entrectinib
2
ensartinib
2
cabozantinib
2
Topotecan
2
Temozolomide
2
Surveys and Questionnaires
2
Radiation
2
LY3023414
2
Gemcitabine
2
Etoposide
2
Cyclophosphamide
2
ulixertinib
1
tipifarnib
1
pegfilgrastim
1
palbociclib
1
olaparib
1
niraparib
1
mirdametinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Capecitabine
×
90 days
×
Clear all
No trials found.